Intracranial Solitary Fibrous Tumour Management: A French Multicentre Retrospective Study
Cancers · 24.01.2023 · 15 (3) · 704
DOI: 10.3390/cancers15030704 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 24.01.2023. Verfasst von Marine Lottin und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Amiens University Hospital, 80054 Amiens, France. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Intracranial solitary fibrous tumour (iSFT) is an exceptional mesenchymal tumour with high recurrence rates. We aimed to analyse the clinical outcomes of newly diagnosed and recurrent iSFTs.
Methods
We carried out a French retrospective multicentre (n = 16) study of histologically proven iSFT cases. Univariate and multivariate Cox models were used to estimate the prognosis value of the age, location, size, WHO grade, and surgical extent on overall survival (OS), progression-free survival (PFS), and local recurrence-free survival (LRFS).
Results
Eighty-eight patients were included with a median age of 54.5 years. New iSFT cases were treated with gross tumour resection (GTR) (n = 75) or subtotal resection (STR) (n = 9) and postoperative radiotherapy (PORT) (n = 32, 57%). The median follow-up time was 7 years. The median OS, PFS, and LRFS were 13 years, 7 years, and 7 years, respectively. Forty-two patients experienced recurrence. Extracranial metastasis occurred in 16 patients. Median OS and PFS after the first recurrence were 6 years and 15.4 months, respectively. A higher histological grade was a prognosis factor for PFS (p = 0.04) and LRFS (p = 0.03). GTR influenced LRFS (p = 0.03).
Conclusion
GTR provided benefits as a first treatment for iSFTs. However, approximately 40% of patients experienced relapse, which remains a challenging state.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Amiens University Hospital, 80054 Amiens, France.
- Department of Radiotherapy, Lille Oscar Lambret Centre, 59000 Lille, France.
- School of Medicine H. Warembourg, Lille University, 59000 Lille, France.
- Lab CRIStAL, Lille University, UMR 9189, 59655 Villeneuve d'Ascq, France.
- Department of Neurosurgery, Montpellier University Hospital, 34295 Montpellier, France.
- Institute of Functional Genomics, Montpellier University, 34000 Montpellier, France.
ORCID-Profile: Marine Lottin, Matthieu Peyre, Sébastien Freppel, Jean-Jacques Lemaire, Nicolas Penel
Zitieren
APA
Lottin, M., Escande, A., Bauchet, L., Albert-Thananayagam, M., Barthoulot, M., Peyre, M., Boone, M., Zouaoui, S., Guyotat, J., Penchet, G., Pallud, J., Dufour, H., Emery, E., Lefranc, M., Freppel, S., Namaki, H., Gueye, E., Lemaire, J. J., Muckensturm, B., …, & Penel, N. (2023). Intracranial Solitary Fibrous Tumour Management: A French Multicentre Retrospective Study. Cancers, 15(3), 704. https://doi.org/10.3390/cancers15030704
Vancouver
Lottin M, Escande A, Bauchet L, Albert-Thananayagam M, Barthoulot M, Peyre M, et al. Intracranial Solitary Fibrous Tumour Management: A French Multicentre Retrospective Study. Cancers. 2023;15(3):704. doi:10.3390/cancers15030704
BibTeX
@article{Lottin2023,
author = {Lottin, Marine and Escande, Alexandre and Bauchet, Luc and Albert-Thananayagam, Marie and Barthoulot, Maël and Peyre, Matthieu and Boone, Mathieu and Zouaoui, Sonia and Guyotat, Jacques and Penchet, Guillaume and Pallud, Johan and Dufour, Henry and Emery, Evelyne and Lefranc, Michel and Freppel, Sébastien and Namaki, Houman and Gueye, Edouard and Lemaire, Jean-Jacques and Muckensturm, Bertrand and Srour, Robin and Derrey, Stéphane and Monfilliette, Apolline and Constans, Jean-Marc and Maurage, Claude-Alain and Chauffert, Bruno and Penel, Nicolas},
title = {Intracranial Solitary Fibrous Tumour Management: A French Multicentre Retrospective Study},
journal = {Cancers},
year = {2023},
volume = {15},
number = {3},
pages = {704},
doi = {10.3390/cancers15030704}
}
EUVIMED